These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37548445)

  • 1. Interval Colorectal Cancer in Inflammatory Bowel Disease: A Review.
    Da Cunha T; Vaziri H
    J Clin Gastroenterol; 2024 Jan; 58(1):1-11. PubMed ID: 37548445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal cancer in inflammatory bowel disease: review of the evidence.
    Keller DS; Windsor A; Cohen R; Chand M
    Tech Coloproctol; 2019 Jan; 23(1):3-13. PubMed ID: 30701345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interval Colorectal Cancer in Inflammatory Bowel Disease: The Role of Guideline Adherence.
    Burke KE; Nayor J; Campbell EJ; Ananthakrishnan AN; Khalili H; Richter JM
    Dig Dis Sci; 2020 Jan; 65(1):111-118. PubMed ID: 31367882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?
    Dyson JK; Rutter MD
    World J Gastroenterol; 2012 Aug; 18(29):3839-48. PubMed ID: 22876036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Grade Dysplasia in Inflammatory Bowel Disease: Indication for Colectomy.
    Olecki EJ; Perez Hoguin RA; King S; Razavi NC; Scow JS
    Dis Colon Rectum; 2023 Feb; 66(2):262-268. PubMed ID: 35714339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
    Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal cancer in elderly-onset inflammatory bowel disease: a 1969-2017 Scandinavian register-based cohort study.
    Everhov ÅH; Erichsen R; Järås J; Pedersen L; Halfvarson J; Askling J; Ekbom A; Ludvigsson JF; Sørensen HT; Olén O
    Aliment Pharmacol Ther; 2022 Oct; 56(7):1168-1182. PubMed ID: 35916190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of Colorectal Cancer in Inflammatory Bowel Disease - the Evolving Landscape.
    Linson EA; Hanauer SB
    Curr Gastroenterol Rep; 2021 Aug; 23(9):16. PubMed ID: 34338892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance and management of colorectal dysplasia and cancer in inflammatory bowel disease: Current practice and future perspectives.
    Wijnands AM; Mahmoud R; Lutgens MWMD; Oldenburg B
    Eur J Intern Med; 2021 Nov; 93():35-41. PubMed ID: 34481721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory bowel disease and its association with colorectal cancer.
    Schechter S
    R I Med; 1995 Jun; 78(6):161-3. PubMed ID: 7626814
    [No Abstract]   [Full Text] [Related]  

  • 11. Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey.
    Baars JE; Kuipers EJ; van Haastert M; Nicolaï JJ; Poen AC; van der Woude CJ
    J Gastroenterol; 2012 Dec; 47(12):1308-22. PubMed ID: 22627504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colonoscopy surveillance for dysplasia and colorectal cancer in patients with inflammatory bowel disease.
    Aalykke C; Jensen MD; Fallingborg J; Jess T; Langholz E; Meisner S; Andersen NN; Riis LB; Thomsen OØ; Tøttrup A
    Dan Med J; 2015 Jan; 62(1):B4995. PubMed ID: 25557336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rates and characteristics of postcolonoscopy colorectal cancer in the Swedish IBD population: what are the differences from a non-IBD population?
    Stjärngrim J; Ekbom A; Hammar U; Hultcrantz R; Forsberg AM
    Gut; 2019 Sep; 68(9):1588-1596. PubMed ID: 30554159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colorectal cancer in inflammatory bowel diseases: a population-based study (1976-2008).
    Peyrin-Biroulet L; Lepage C; Jooste V; Guéant JL; Faivre J; Bouvier AM
    Inflamm Bowel Dis; 2012 Dec; 18(12):2247-51. PubMed ID: 22467511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal cancer surveillance in inflammatory bowel disease: the search continues.
    Ahmadi A; Polyak S; Draganov PV
    World J Gastroenterol; 2009 Jan; 15(1):61-6. PubMed ID: 19115469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients' knowledge and fear of colorectal cancer risk in inflammatory bowel disease.
    Lopez A; Collet-Fenetrier B; Belle A; Peyrin-Biroulet L
    J Dig Dis; 2016 Jun; 17(6):383-91. PubMed ID: 27129893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinogenesis in inflammatory bowel disease.
    Herszenyi L; Miheller P; Tulassay Z
    Dig Dis; 2007; 25(3):267-9. PubMed ID: 17827953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic surveillance of colorectal cancer in inflammatory bowel diseases: a review of the literature.
    Vitello A; Shahini E; Macaluso FS; Morreale GC; Sinagra E; Pallio S; Maida M
    Expert Rev Anticancer Ther; 2020 Oct; 20(10):851-863. PubMed ID: 32811225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal cancer in inflammatory bowel disease: a shift in risk?
    Gallinger ZR; Weizman AV
    Expert Rev Anticancer Ther; 2014 Jul; 14(7):847-56. PubMed ID: 24621115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory Bowel Disease-Associated Colorectal Cancer Epidemiology and Outcomes: An English Population-Based Study.
    Birch RJ; Burr N; Subramanian V; Tiernan JP; Hull MA; Finan P; Rose A; Rutter M; Valori R; Downing A; Morris EJA
    Am J Gastroenterol; 2022 Nov; 117(11):1858-1870. PubMed ID: 36327438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.